CAPTRUST Financial Advisors
ASXC

CAPTRUST Financial Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,539
Closed -$4K – 4263
2022
Q2 		$4K Hold
9,539
– – ﹤0.01% 4234
2022
Q1 		$6K Hold
9,539
– – ﹤0.01% 4098
2021
Q4 		$11K Buy
9,539
+1,954
+26% +$3.02K ﹤0.01% 3673
2021
Q3 		$14K Buy
7,585
+85
+1% +$191 ﹤0.01% 3414
2021
Q2 		$24K Hold
7,500
– – ﹤0.01% 2986
2021
Q1 		$24K Buy
+7,500
New +$27.2K ﹤0.01% 2899
2019
Q4 		– Sell
-46
Closed – – 1877
2019
Q3 		$0 Buy
+46
New +$625 ﹤0.01% 2035

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

CAPTRUST Financial Advisors's ASXC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 9,539 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in ASXC in Q3 2019 and held it in 7 quarters. The position peaked at $24K in Q2 2021. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 9,539 Asensus Surgical, Inc. shares in Q3 2022, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in Asensus Surgical, Inc. in Q3 2019 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Asensus Surgical, Inc. position peaked at $24K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.